20 articles
Completed study of 102 older adults tested whether combined interventions can preserve brain volume and improve mobility through muscle-brain axis.
French researchers followed 1,028 people with mild cognitive complaints to understand how dementia develops over time.
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
32-person study explores how intermittent fasting affects blood vessel function and brain performance through protective pathways.
18-month trial tested omega-3 supplementation in 774 older adults with low DHA/EPA levels and memory concerns to prevent cognitive decline.
Major study reveals sleep breathing disorders may accelerate brain aging and memory decline, even before cognitive symptoms appear.
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
A 210-person trial tests whether 5-month music therapy programs โ and robotic assistants โ can slow cognitive decline in older adults.
Large 6-year study tested dietary interventions including caloric restriction and omega-3s in 330 people with mild cognitive impairment.
Personalized treatment approach targeting multiple causes of cognitive decline outperformed standard care in 9-month trial.
Researchers at Duke University tested a blood-based biomarker to stratify Alzheimer's patients from healthy adults, aiming to enable earlier detection.
Clinical trial explores how targeted light treatment could restore circadian rhythms and improve brain function in mild cognitive impairment.
180-person study explores whether Mediterranean eating patterns can prevent cognitive decline in overweight seniors.
12-week study reveals how aerobic and strength training improve cognitive performance by altering stress hormones and brain proteins.
A completed RCT tests whether 6 months of moderate aerobic exercise protects memory and brain structure in older adults at genetic risk for Alzheimer's.
Small trial tested whether fish oil and alpha lipoic acid could slow Alzheimer's by reducing oxidative stress markers in blood.
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
A completed pharmacokinetic study tracks NAD precursors NR and NMN from bloodstream to brain, filling a critical gap in human data.
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
King's College study tests whether simple chewing and fasting patterns can enhance cognitive function and neurogenesis in older adults.
